Very low response rates to anti-PD1 antibodies were observed in patients with chronic lymphocytic leukemia (CLL)1,2, a malignancy of mature B cells that accumulate in blood, LNs, and bone marrow. Here, PDCD1 is linked to B-cell chronic lymphocytic leukemia.